247 related articles for article (PubMed ID: 35814659)
1. Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant
Mirzaei R; Alikhani MY; Arciola CR; Sedighi I; Irajian G; Jamasbi E; Yousefimashouf R; Bagheri KP
Front Microbiol; 2022; 13():869650. PubMed ID: 35814659
[TBL] [Abstract][Full Text] [Related]
2. Prevention, inhibition, and degradation effects of melittin alone and in combination with vancomycin and rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis.
Mirzaei R; Alikhani MY; Arciola CR; Sedighi I; Yousefimashouf R; Bagheri KP
Biomed Pharmacother; 2022 Mar; 147():112670. PubMed ID: 35123230
[TBL] [Abstract][Full Text] [Related]
3. A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.
Jalalifar S; Razavi S; Mirzaei R; Irajian G; Pooshang Bagheri K
Front Microbiol; 2023; 14():1269392. PubMed ID: 38370578
[TBL] [Abstract][Full Text] [Related]
4. Antibiofilm effect of melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and -
Mirzaei R; Esmaeili Gouvarchin Ghaleh H; Ranjbar R
Front Microbiol; 2023; 14():1030401. PubMed ID: 36910230
[TBL] [Abstract][Full Text] [Related]
5. The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin.
Mirzaei R; Yousefimashouf R; Arabestani MR; Sedighi I; Alikhani MY
PLoS One; 2022; 17(11):e0277287. PubMed ID: 36350834
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
7. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Al-Ani I; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
[TBL] [Abstract][Full Text] [Related]
9. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
[TBL] [Abstract][Full Text] [Related]
10. Eradication of vancomycin-resistant Staphylococcus aureus on a mouse model of third-degree burn infection by melittin: An antimicrobial peptide from bee venom.
Bevalian P; Pashaei F; Akbari R; Pooshang Bagheri K
Toxicon; 2021 Aug; 199():49-59. PubMed ID: 34087287
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of melittin with mupirocin: A study against methicillin-resistant
Hakimi Alni R; Tavasoli F; Barati A; Shahrokhi Badarbani S; Salimi Z; Babaeekhou L
Saudi J Biol Sci; 2020 Oct; 27(10):2580-2585. PubMed ID: 32994714
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a Novel Antibiotic Drug Combination Toward Multidrug-Resistant Ocular Pathogens.
Gowtham L; Wozniak RAF; Dunman PM; Sheba E; Garg P; Joseph J
Cornea; 2024 Mar; ():. PubMed ID: 38537125
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antibacterial Activity of Designed Trp-Containing Antibacterial Peptides in Combination With Antibiotics Against Multidrug-Resistant
Shang D; Liu Y; Jiang F; Ji F; Wang H; Han X
Front Microbiol; 2019; 10():2719. PubMed ID: 31824473
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
Ein ME; Smith NJ; Aruffo JF; Heerema MS; Bradshaw MW; Williams TW
Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis.
Kang-Birken SL
Pharmacotherapy; 2000 Jun; 20(6):673-8. PubMed ID: 10853623
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
Yan Q; Karau MJ; Raval YS; Patel R
Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
[TBL] [Abstract][Full Text] [Related]
19. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
20. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
Albac S; Labrousse D; Hayez D; Anzala N; Bonnot D; Chavanet P; Aslangul E; Croisier D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
